BlackRock Investment Management’s Fortress Biotech FBIO Stock Holding History

BlackRock Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$326K	Hold	8,053	–	–	﹤0.01%	3148
2016 Q3	$359K	Sell	8,053 -22	-0.3%	-$936	﹤0.01%	3142
2016 Q2	$326K	Buy	8,075 +7,683	+1,960%	+$358K	﹤0.01%	3210
2016 Q1	$18K	Hold	392	–	–	﹤0.01%	3403
2015 Q4	$16K	Buy	392 +26	+7%	+$1.09K	﹤0.01%	3497
2015 Q3	$14K	Hold	366	–	–	﹤0.01%	3547
2015 Q2	$18K	Buy	366 +26	+8%	+$1.33K	﹤0.01%	3471
2015 Q1	$20K	Hold	340	–	–	﹤0.01%	3444
2014 Q4	$12K	Hold	340	–	–	﹤0.01%	3604
2014 Q3	$11K	Sell	340 -3	-0.9%	-$80	﹤0.01%	3627
2014 Q2	$9K	Sell	343 -5,684	-94%	-$150K	﹤0.01%	3663
2014 Q1	$179K	Buy	6,027 +1,140	+23%	+$44.5K	﹤0.01%	3246
2013 Q4	$193K	Hold	4,887	–	–	﹤0.01%	3222
2013 Q3	$514K	Buy	4,887 +986	+25%	+$121K	﹤0.01%	2918
2013 Q2	$503K	Buy	+3,901	New	+$575K	﹤0.01%	2851

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Investment Management's FBIO Position: Q4 2016 in Review

BlackRock Investment Management held its Fortress Biotech (FBIO) position steady in Q4 2016 at 8,053 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3148.

BlackRock Investment Management first reported a position in FBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $514K in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.

BlackRock Investment Management held 8,053 shares of Fortress Biotech worth $326K as of Q4 2016.
BlackRock Investment Management left its Fortress Biotech share count unchanged in Q4 2016.
Fortress Biotech made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3148 holding.
BlackRock Investment Management first reported a position in Fortress Biotech in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Fortress Biotech position peaked at $514K in Q3 2013.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.